Overview

Japanese Primary Prevention Project With Aspirin

Status:
Unknown status

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the balance between the risks and benefits of primary prevention by Aspirin in elderly Japanese patients with one or more cerebro/cardiovascular risk factors

Phase:

Phase 4

Details

Lead Sponsor:

Ministry of Health, Labour and Welfare, Japan

Collaborators:

Bayer
Japan Heart Foundation

Treatments:

Aspirin